Researchers sequenced mothers who experienced preterm birth and found a possible role for steroid signaling in birth timing.
Researchers from Stanford University reported in a pilot study that seven RNA transcripts could predict preterm birth.
They acknowledge that while the technical hurdles of proteomic test development have become manageable, commercialization is still a major challenge.
Researchers used a machine learning approach to link variants in the PPARG gene to abnormal brain development seen among preterm infants.
The researchers said that better diagnostics are needed to distinguish between false preterm labor and true preterm labor to prevent unnecessary treatment.
In a wide-ranging discussion, the two leaders touched upon vaccine development, infant mortality, US education, research funding, machine learning, and precision medicine.
A new genome-wide association study involving data from thousands of 23andMe customers implicated six loci in gestational duration or preterm birth risk.
The study details the validation of the mass spec-based preterm birth test, which the company launched nationwide last month through its agreement with LabCorp.
In PLOS this week: variants linked to risk of preterm birth, microbiome of New York's money, and more.
The agreement will allow Sera to leverage LabCorp's sales force and networks, but similar deals have failed to deliver for proteomics firms in the past.
The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.
Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.
CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.
In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.